Volume 26, Number 3—March 2020
Research
Genomic and Phenotypic Variability in Neisseria gonorrhoeae Antimicrobial Susceptibility, England
Table 1
Univariate and multivariable analyses comparing the epidemiologic characteristics of cases of Neisseria gonorrhoeae between 2 phylogenetic lineages, England*
Characteristics | Lineage, no. |
Lineage A outcomes |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Univariate |
Multivariable |
|||||||||
A | B | cOR | 95% CI | p value | aOR | 95% CI | p value | |||
Total |
838 |
439 |
||||||||
Year | ||||||||||
2013 | 220 | 106 | Ref | |||||||
2014 | 210 | 123 | 0.82 | 0.60–1.13 | 0.234 | |||||
2015 | 260 | 107 | 1.17 | 0.85–1.62 | 0.339 | |||||
2016 |
148 |
103 |
0.69 |
0.49–0.98 |
0.035 |
|||||
Clinic location | ||||||||||
Outside London | 630 | 136 | Ref | Ref | ||||||
London |
463 |
109 |
3.73 |
2.86–4.88 |
<0.001 |
1.74 |
1.27–2.67 |
0.001 |
||
Sex and sexual orientation | ||||||||||
MSM | 630 | 136 | Ref | Ref | ||||||
MSW | 150 | 154 | 0.21 | 0.15–0.29 | <0.001 | 0.33 | 0.23–0.47 | <0.001 | ||
F |
57 |
149 |
0.08 |
0.05–0.12 |
<0.001 |
0.14 |
0.09–0.22 |
<0.001 |
||
Age, y | ||||||||||
≤24 | 188 | 196 | Ref | Ref | ||||||
25–34 | 342 | 161 | 2.21 | 1.67–2.93 | <0.001 | 1.14 | 0.83–1.59 | 0.413 | ||
≥35 |
308 |
82 |
3.92 |
2.81–5.46 |
<0.001 |
1.68 |
1.16–2.40 |
0.006 |
||
Ethnicity | ||||||||||
White | 586 | 238 | Ref | Ref | ||||||
Black Caribbean | 51 | 81 | 0.26 | 0.17–0.38 | <0.001 | 0.49 | 0.32–0.76 | 0.001 | ||
Black African | 27 | 20 | 0.55 | 0.30–1.00 | 0.046 | 0.84 | 0.43–1.64 | 0.607 | ||
Black Other | 6 | 4 | 0.61 | 0.17–2.18 | 0.442 | 0.57 | 0.14–2.37 | 0.441 | ||
Asian | 57 | 17 | 1.36 | 0.78–2.39 | 0.280 | 1.86 | 1.01–3.45 | 0.048 | ||
Other | 24 | 8 | 1.22 | 0.54–2.75 | 0.634 | 0.99 | 0.41–2.44 | 0.999 | ||
Mixed |
62 |
43 |
0.59 |
0.39–0.89 |
0.011 |
0.82 |
0.51–1.32 |
0.413 |
||
Place of birth | ||||||||||
United Kingdom | 473 | 309 | Ref | |||||||
Not United Kingdom |
305 |
102 |
1.95 |
1.49–2.56 |
<0.001 |
|||||
Symptomatic infection | ||||||||||
No | 219 | 119 | Ref | |||||||
Yes |
526 |
277 |
1.03 |
0.79–1.35 |
0.818 |
|||||
New STI diagnosis <1 year, excluding HIV | ||||||||||
No or unknown | 615 | 363 | Ref | |||||||
Yes |
223 |
75 |
1.75 |
1.31–2.35 |
<0.001 |
|||||
HIV status | ||||||||||
Negative or unknown | 653 | 398 | Ref | |||||||
Positive |
185 |
41 |
2.75 |
1.91–3.96 |
<0.001 |
|||||
Number of partners in the United Kingdom <3 months of diagnosis | ||||||||||
0 | 27 | 20 | Ref | |||||||
1 | 175 | 162 | 0.80 | 0.43–1.48 | 0.478 | |||||
≥2 |
304 |
167 |
1.35 |
0.73–2.48 |
0.335 |
|||||
Travel-associated sexual partnerships <3 months of diagnosis | ||||||||||
No | 442 | 325 | Ref | |||||||
Yes | 64 | 24 | 1.96 | 1.20–3.21 | 0.006 |
*The multivariable model was adjusted for location, gender and sexual orientation, age, and ethnicity. Bold text indicates statistical significance (p<0.05 and 95% CI does not cross 1.0). aOR, adjusted odds ratio; cOR, crude odds ratio; MSM, men who have sex with men; MSW, men who reported sexual activity exclusively with women; Ref, referent; STI, sexually transmitted infection.